Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This connection may be attributable to lower iron levels.
Nearly a quarter of lean HIV-positive people in a recent study had NAFLD, and 16% of them developed fibrosis.
A new study analyzed how non-alcoholic fatty liver disease affects maternal health outcomes.
Non-alcoholic fatty liver disease can be driven by toxin exposure.
Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.
Instead of non-alcoholic fatty liver disease, they suggest calling it metabolic-associated fatty liver disease.
Researchers believe this finding may have implications for human health.
Non-alcoholic steatohepatitis, the more severe form of non-alcoholic fatty liver disease, is highly prevalent in the HIV population.
New research is emerging about how the respiratory virus spreads and how people can protect themselves and others.
According to a study, Egrifta can improve fatty liver disease in people with HIV.
A number of treatments for non-alcoholic steatohepatitis (NASH) have shown promise in recent mid-stage trials.
Here are some ways that fatty liver diseases like NAFLAD and NASH are managed.
Terri Milton’s experience living with NASH has taught her not to let the disease get the best of her and to enjoy life.
It involves the buildup of fat in the liver.
Houstonian Terri Milton is determined not to let advanced fatty liver disease get the best of her.
Liver scarring was associated with poorer health outcomes and a higher risk of death for people with non-alcoholic fatty liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.